Ankrin Therapeutics ApS
CVR 39788705 · Private limited company (ApS) · Dissolved after bankruptcy
Ankrin Therapeutics ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Ankrin Therapeutics ApS went bankrupt on – 6.5 years after it was founded. 5 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2022) shows equity of DKK -4.4m and a net result of DKK -2.7m.
Bankruptcy
- Bankruptcy date
- Status
- Dissolved after bankruptcy
- Age at bankruptcy
- 6.5 years
Company details
- CVR number
- 39788705
- Status
- Dissolved after bankruptcy
- Company type
- Private limited company (ApS)
- Founded
- Ceased
- Address
- Nordre Fasanvej 215
2000 Frederiksberg - Municipality
- Frederiksberg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 4 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -121.6% |
| Current ratio | 679% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2022 | 2021 |
|---|---|---|
| Gross profit | DKK -1.0m | DKK -2.4m |
| Net profit | DKK -2.7m | DKK -4.5m |
| Equity | DKK -4.4m | DKK -1.7m |
| Total assets | DKK 3.7m | DKK 6.6m |
| Cash | DKK 2.2m | – |
| Short-term debt | DKK 538k | – |
| Avg. employees | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2023 – 31 Dec 2023 | 192 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 181 | ||
| 1 Jan 2021 – 31 Dec 2021 | 182 | ||
| 1 Jan 2020 – 31 Dec 2020 | 186 | Late | |
| 16 Aug 2018 – 31 Dec 2019 | 139 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Thomas Michael Frimurer | ||
| CEO | Anja Groth | ||
| Board | Ulrik Svane Sørensen | ||
| Board | Thomas Michael Frimurer | ||
| Board | Anja Groth | ||
| Board | Ulrik Svane Sørensen | ||
| Board | Jimmy Arnold Van heusden | ||
| Owner (50%) | Groth Holdings ApS | ||
| Owner (50%) | Frimurer Holdings ApS | ||
| Owner (25%) | Svasø Holding ApS | ||
| Owner (33%) | Groth Holdings ApS | ||
| Owner (33%) | Frimurer Holdings ApS | ||
| Auditor | PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab | ||
| Founder | Groth Holdings ApS | ||
| Founder | Frimurer Holdings ApS |
Address history (2 moves)
| Nordre Fasanvej 215, 2000 Frederiksberg | |
| c/o BioInnovation Institute, Ole Maaløes Vej 3, 2200 København N | |
| c/o Direktør Anja Groth, Plantagevej 52, 2820 Gentofte |
Former names
| Ankrin Therapeutics ApS | – |
| Ankrin Therapeutics IvS | – |
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
- ACCELERACE MANAGEMENT A/S Active
Similar companies in Frederiksberg
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about Ankrin Therapeutics ApS
Has Ankrin Therapeutics ApS gone bankrupt?
Yes. Ankrin Therapeutics ApS went bankrupt on 25 February 2025.
Who is the auditor of Ankrin Therapeutics ApS?
Ankrin Therapeutics ApS most recently used PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab.
When was Ankrin Therapeutics ApS founded?
Ankrin Therapeutics ApS was founded on 16 August 2018.
What is the equity of Ankrin Therapeutics ApS?
Equity was DKK -4.4m according to the annual report for the period ending 31 December 2022.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.